Xiuying Xiao

机构：Shanghai Jiao Tong University, Renji Hospital · ORCID：0000-0002-9873-0380

发表论文 88 篇 · 总被引 2609 次 · h-index 25

代表论文

• Interplay between gut microbial communities and metabolites modulates pan-cancer immunotherapy responses (2025 · Cell Metabolism · 被引 67)
• Gut microbiome for predicting immune checkpoint blockade-associated adverse events (2024 · Genome Medicine · 被引 55)
• CLDN18.2–targeting antibody–drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial (2025 · Nature Medicine · 被引 40)
• The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial (2025 · Nature Medicine · 被引 21)
• Optimizing anti-PD-1/PD-L1 therapy efficacy and fecal microbiota transplantation donor selection through gut mycobiome-based enterotype (2025 · Cell Reports · 被引 17)
• Pan-Cancer Analysis of Oncogenic MET Fusions Reveals Distinct Pathogenomic Subsets with Differential Sensitivity to MET-Targeted Therapy (2025 · Cancer Discovery · 被引 17)